Dennis Christensen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Juvenile Idiopathic Arthritis

Top Venues

Nature communications

Immunological reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Dennis Christensen
Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of Challenges. Pharmaceutics 16 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Dennis Christensen
Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of Challenges. Pharmaceutics 16 (1) (2023)
Dennis Christensen
Head-to-Head Comparison of Novel Vaccine Technologies Comes with a Minefield of Challenges. Pharmaceutics 16 (1) (2023)
Simon Daniel van Haren, Gabriel K Pedersen, Azad Kumar, Tracy J Ruckwardt, Syed Moin, Ian N Moore, Mahnaz Minai, Mark Liu, Jensen Pak, Francesco Borriello, Simon Doss-Gollin, Elisabeth M S Beijnen, Saima Ahmed, Michaela Helmel, Peter Andersen, Barney S Graham, Hanno Steen, Dennis Christensen, Ofer Levy
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns. Nature communications 13 (1) (2022)
Lorena Garcia-Del Rio, Patricia Diaz-Rodriguez, Gabriel Kristian Pedersen, Dennis Christensen, Mariana Landín
Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis. Advanced healthcare materials 11 (11) (2022)
Judith Schick, Johanna Schäfer, Christian Alexander, Stefanie Dichtl, Peter J Murray, Dennis Christensen, Ursula R Sorg, Klaus Pfeffer, Ulrike Schleicher, Roland Lang
Cutting Edge: TNF Is Essential for Mycobacteria-Induced MINCLE Expression, Macrophage Activation, and Th17 Adjuvanticity. Journal of immunology (Baltimore, Md. : 1950) 205 (2) (2020)
Virgil Schijns, Alberto Fernández-Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, İhsan GÜrsel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz-de-Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen, Ed C Lavelle
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological reviews 296 (1) (2020)